Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FFBZ3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,849
Award facts
- Contract value 100% obligated
- $32,848.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,848.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 18, 2026, and carries no set-aside designation. DMS Pharmaceutical Group Inc. will perform the work at its Park Ridge facility and will serve as the prime contractor with no identified subcontractors involved in this award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. The parent contract, valued at $499,999,999 and awarded on November 13, 2025, extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional prime vendor contractor within the military healthcare supply chain. The company's extensive product portfolio includes branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals, supporting recurring medical supply needs across the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FFBZ3?
SPE2DR26FFBZ3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FFBZ3 worth?
The government has obligated $32,849 on SPE2DR26FFBZ3.
Is contract SPE2DR26FFBZ3 an order under another contract?
Yes. SPE2DR26FFBZ3 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBZ3 competed?
The extent of competition for SPE2DR26FFBZ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award